Pursuant to the audit conducted by Medicines and Healthcare products Regulatory Agency (MHRA), Bafna Pharmaceuticals has informed that their Facility has got Renewal approval as per the Guidelines of European Good Manufacturing Practices (EUGMP).
The above information is a part of company’s filings submitted to BSE.